Skip to main content

SR 201 — Kentucky

A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.

Passed one chamber 2026RS session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Encourage Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in the Commonwealth.

Official abstract, as published by the legislature.

  • SR 201 is a resolution in the Kentucky Senate, 2026RS session, introduced March 26, 2026.
  • Sponsored by S. Funke Frommeyer and R. Stivers.
  • Current status: passed one chamber.
  • Most recent action (April 1, 2026): adopted by voice vote.
  • Subjects: Drugs And Medicines, Economic Development, Science And Technology.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: S. Funke Frommeyer, R. Stivers

History

  1. Introduced, completed
  2. Adopted by Senate, completed, current stage
  1. Senate introduced in Senate Milestone
  2. Senate to Committee on Committees (S)
  3. Senate to Senate Floor
  4. Senate adopted by voice vote Milestone Latest

Source: Open States. Last checked November 11, 2026. How we keep this accurate ›